← Back to Search

Standard Therapy (ST) for Myofascial Pain Syndrome (T-PIMPS Trial)

Phase 4
Waitlist Available
Led By Joshua J Oliver, MD
Research Sponsored by Madigan Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60-72 hours
Awards & highlights

T-PIMPS Trial Summary

Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial

Eligible Conditions
  • Myofascial Pain Syndrome
  • Lower Back Pain

T-PIMPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60-72 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60-72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain reduction
Secondary outcome measures
Functional Improvement
Other outcome measures
Follow-up measurement of function
Follow-up measurement of pain

T-PIMPS Trial Design

3Treatment groups
Active Control
Group I: Standard Therapy (ST)Active Control3 Interventions
ST will consist of 975mg of Acetaminophen PO and either 30mg of Ketorolac IM or 15 mg IV. Upon discharge ST will consist of prescriptions for acetaminophen 650mg every 4 hours by mouth, Ibuprofen 400mg every 4 hours by mouth, and 10 mg of cyclobenzaprine nightly by mouth. Additionally, participants will be provided a handout going over these medications and the use of heat for low back pain and instructions on the performance of McKenzie stretching exercises for low back pain.4
Group II: ST plus Trigger Point Injections (TPI) with 8 mL of 0.5 percent BupivacaineActive Control3 Interventions
ST plus TPI with 8 mL of 0.5 percent Bupivacaine
Group III: ST plus TPI with 8 mL of Normal Saline (NS)Active Control3 Interventions
ST plus TPI with 8 mL of Normal Saline

Find a Location

Who is running the clinical trial?

Madigan Army Medical CenterLead Sponsor
48 Previous Clinical Trials
18,024 Total Patients Enrolled
Joshua J Oliver, MDPrincipal InvestigatorMadigan AMC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~42 spots leftby Apr 2025